Drug recall · August 9, 2017
Amantadine HCl Capsules recall
Why: Labeling; Label Mix up; cartons labeled as Amantadine HCl 100 mg Capsules contain unit dose blister cards of Cyclobenzaprine HCl Tablet, USP 5 mg
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amantadine HCl Capsules, USP, 100 mg, Rx Only, 50 Capsules (5x10) Unit Dose Cartons, Manufactured for: AvKARE Inc, Pulaski, TN 38478 --- NDC: 50268-0069-15
- Lots / codes
Lot: 16710, exp 07/2018
- Quantity
- 1,483 cartons
- Company
- Apace KY LLC, Fountain Run, KY
- Distribution
- KY
- Initiated
- June 19, 2017 · Voluntary: Firm initiated
- Classified
- July 31, 2017
- Reported
- August 9, 2017
- Ended
- May 4, 2018
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amantadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.